ReviewDrugs & aging2015
Therapeutic Strategies to Treat Dry Eye in an Aging Population.
Review in Drugs & aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 37 citations in OpenAlex.
- Comparison of two intense pulsed light patterns for treating patients with meibomian gland dysfunction.International ophthalmology · 2020Trial
- A novel TRPM8 agonist relieves dry eye discomfort.BMC ophthalmology · 2017Trial
- Prospective Evaluation of RedTouch Laser in the Treatment of Dry Eye Disease Secondary to Meibomian Gland Dysfunction.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- The Management of Dry Eye Disease: Proceedings of Italian Dry Eye Consensus Group Using the Delphi Method.Journal of clinical medicine · 2022Article
- Dry Eye Disease after Cataract Surgery: Study of its Determinants and Risk FactorsTurkish journal of ophthalmology · 2020Observational
- The efficacy and safety of qiming granule in dry eye disease: Protocol for systematic review and meta-analysis.Medicine · 2019Article
- Unexplained cough: it is time to rule out Sjogren's syndrome.Clinical rheumatology · 2018Article
- Glaucoma therapy: preservative-free for all?Clinical ophthalmology (Auckland, N.Z.) · 2018Review
- Neuropathic pain and dry eye.The ocular surface · 2018Review
- A clinical utility assessment of the automatic measurement method of the quality of Meibomian glands.Biomedical engineering online · 2017Article
- Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye.Clinical ophthalmology (Auckland, N.Z.) · 2017Article
- Intense pulsed light for evaporative dry eye disease.Clinical ophthalmology (Auckland, N.Z.) · 2017Review
- Dry eye syndrome model established in rabbits via mitomycin C injection in the lacrimal gland.Taiwan journal of ophthalmologyArticle
- Quality of life improvement in dry eye patients after intense pulsed light therapy compared to punctal plugs.Oman journal of ophthalmologyArticle
- Can lacrimal punctum size link to the severity of dry eye disease?Taiwan journal of ophthalmologyArticle
- The potential role of neuropathic mechanisms in dry eye syndromes.Journal of optometryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Dry eye (DE) is a prevalent ocular disease that primarily affects the elderly. Affecting up to 30% of adults aged 50 years and older, DE affects both visual function and quality of life. Symptoms of DE, including ocular pain (aching, burning), visual disturbances, and tearing, can be addressed with therapeutic agents that target dysfunction of the meibomian glands, lacrimal glands, goblet cells, ocular surface, and/or neural network. This review provides an overview of the efficacy, use, and limitations of current therapeutic interventions being used to treat DE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.